Glazer Capital LLC’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
380,933
-9,312
-2% -$99.5K 0.1% 194
2026
Q1
$4.12M Sell
390,245
-9,552
-2% -$101K 0.09% 188
2025
Q4
$4.18M Sell
399,797
-13,652
-3% -$142K 0.11% 143
2025
Q3
$4.28M Sell
413,449
-7,559
-2% -$78.1K 0.14% 130
2025
Q2
$4.32M Buy
421,008
+344
+0.1% +$3.5K 0.15% 96
2025
Q1
$4.24M Buy
+420,664
New +$4.23M 0.2% 74

Other funds holding TDAC

Glazer Capital LLC's TDAC Position: Q2 2026 in Review

Glazer Capital LLC reduced its Translational Development Acquisition Corp (TDAC) stake by 2.4% in Q2 2026, selling an estimated $99.5K and leaving 380,933 shares worth $4.07M. The position accounts for 0.1% of the portfolio, ranked #194.

Glazer Capital LLC first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.32M in Q2 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Glazer Capital LLC held 380,933 shares of Translational Development Acquisition Corp worth $4.07M as of Q2 2026.
  • Glazer Capital LLC sold 9,312 Translational Development Acquisition Corp shares in Q2 2026, an estimated $99.5K.
  • Translational Development Acquisition Corp made up 0.1% of Glazer Capital LLC's portfolio in Q2 2026, its #194 holding.
  • Glazer Capital LLC first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • Glazer Capital LLC's Translational Development Acquisition Corp position peaked at $4.32M in Q2 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.